N-(Imidazolidin-2-ylidene)-1-arylmethanamine Oxides: Synthesis, Structure and Pharmacological Evaluation

about

N-(Imidazolidin-2-ylidene)-1-arylmethanamine Oxides: Synthesis, Structure and Pharmacological Evaluation

Item

http://www.wikidata.org/entity/Q58834260

description

im November 2011 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 14 November 2011

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2011

@uk

name

N-(Imidazolidin-2-ylidene)-1-a ...... and Pharmacological Evaluation

@en

N-(Imidazolidin-2-ylidene)-1-a ...... and Pharmacological Evaluation

@nl

type

Item

label

N-(Imidazolidin-2-ylidene)-1-a ...... and Pharmacological Evaluation

@en

N-(Imidazolidin-2-ylidene)-1-a ...... and Pharmacological Evaluation

@nl

prefLabel

N-(Imidazolidin-2-ylidene)-1-a ...... and Pharmacological Evaluation

@en

N-(Imidazolidin-2-ylidene)-1-a ...... and Pharmacological Evaluation

@nl

P1476

N-(Imidazolidin-2-ylidene)-1-a ...... and pharmacological evaluation

@en

P2093

Apolonia Rybczyńska

http://www.w3.org/2001/XMLSchema#string

Artur Lehmann

http://www.w3.org/2001/XMLSchema#string

Helena Watts

http://www.w3.org/2001/XMLSchema#string

Mervyn Maze

http://www.w3.org/2001/XMLSchema#string

Shayna Laird

http://www.w3.org/2001/XMLSchema#string

P2860

A short history of SHELX

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects

alpha2-Adrenoceptor agonists: shedding light on neuroprotection?

Cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild-type and D79N alpha2A-adrenoceptor transgenic mice

Self-Consistent Reaction Field Model for Aqueous and Nonaqueous Solutions Based on Accurate Polarized Partial Charges

Synthesis, structure, and binding of some 2-imidazolines to rat brain alfa-1 and alfa-2-adrenergic receptors.

Imidazoline receptors, novel agents and therapeutic potential.

Imidazoline antihypertensive drugs: a critical review on their mechanism of action.

Pharmacological prospects for alpha 2-adrenoceptor antagonist therapy.

P304

33-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ARDP.201100028

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

345

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22083875

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

drug discovery